Literature DB >> 24081971

Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association.

Steven E Lipshultz, M Jacob Adams, Steven D Colan, Louis S Constine, Eugene H Herman, Daphne T Hsu, Melissa M Hudson, Leontien C Kremer, David C Landy, Tracie L Miller, Kevin C Oeffinger, David N Rosenthal, Craig A Sable, Stephen E Sallan, Gautam K Singh, Julia Steinberger, Thomas R Cochran, James D Wilkinson.   

Abstract

Entities:  

Keywords:  AHA Scientific Statements; adolescent; antineoplastic agents; cancer; children; prevention and control; toxicity

Mesh:

Substances:

Year:  2013        PMID: 24081971     DOI: 10.1161/CIR.0b013e3182a88099

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  157 in total

1.  Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial.

Authors:  Melissa M Hudson; Wendy Leisenring; Kayla K Stratton; Nina Tinner; Brenda D Steen; Susan Ogg; Linda Barnes; Kevin C Oeffinger; Leslie L Robison; Cheryl L Cox
Journal:  J Clin Oncol       Date:  2014-11-03       Impact factor: 44.544

Review 2.  Modulation of cardiovascular toxicity in Hodgkin lymphoma: potential role and mechanisms of aerobic training.

Authors:  Anthony F Yu; Lee W Jones
Journal:  Future Cardiol       Date:  2015-08-03

3.  Anthracycline-induced cardiomyopathy: The search continues.

Authors:  Agnes S Kim; Steven R Bergmann
Journal:  J Nucl Cardiol       Date:  2015-12-08       Impact factor: 5.952

4.  Left ventricular mass and ambulatory blood pressure are increased in long-term survivors of childhood cancer after autologous SCT.

Authors:  A Vatanen; T H Ojala; T Sarkola; M Turanlahti; T Jahnukainen; U M Saarinen-Pihkala; K Jahnukainen
Journal:  Bone Marrow Transplant       Date:  2016-02-01       Impact factor: 5.483

Review 5.  An update on cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman
Journal:  Trends Cardiovasc Med       Date:  2014-07-22       Impact factor: 6.677

Review 6.  Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management.

Authors:  Jean Domercant; Nichole Polin; Eiman Jahangir
Journal:  Ochsner J       Date:  2016

Review 7.  Radiation-Induced Cardiovascular Toxicity: Mechanisms, Prevention, and Treatment.

Authors:  Johan Spetz; Javid Moslehi; Kristopher Sarosiek
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-03-20

8.  Aerobic Exercise During Early Murine Doxorubicin Exposure Mitigates Cardiac Toxicity.

Authors:  Fei Wang; Brian Iskra; Eugenie Kleinerman; Claudia Alvarez-Florez; Thomas Andrews; Angela Shaw; Joya Chandra; Keri Schadler; Gregory J Aune
Journal:  J Pediatr Hematol Oncol       Date:  2018-04       Impact factor: 1.289

9.  Caring for the adult survivor of Hodgkin lymphoma: highlighting the need for care coordination.

Authors:  Emily Tonorezos; Linda Overholser
Journal:  JAMA Intern Med       Date:  2015-06       Impact factor: 21.873

Review 10.  Changing Hearts and Minds: Improving Outcomes in Cancer Treatment-Related Cardiotoxicity.

Authors:  Nonniekaye Shelburne; Naoko I Simonds; Bishow Adhikari; Michael Alley; Patrice Desvigne-Nickens; Eileen Dimond; Kelly Filipski; Lisa Gallicchio; Lori Minasian
Journal:  Curr Oncol Rep       Date:  2019-01-30       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.